Global Carcinoembryonic Antigen (CEA) Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 93

Report ID: 1757

Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion.
Increasing consumption of alcohol and sedentary lifestyle are likely to boost the growth of colorectal cancer over the forecast period.
In 2018, the global Carcinoembryonic Antigen (CEA) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Carcinoembryonic Antigen (CEA) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Carcinoembryonic Antigen (CEA) development in United States, Europe and China.

The key players covered in this study
Roche Diagnostics
Abbott Diagnostics
Quest Diagnostics
...

Market segment by Type, the product can be split into
CD66a
CD66b
CD66c
CD66d
CD66e
CD66f

Market segment by Application, split into
Colorectal Cancer
Pancreatic Cancer
Ovarian Cancer
Breast Cancer
Thyroid Cancer
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Carcinoembryonic Antigen (CEA) status, future forecast, growth opportunity, key market and key players.
To present the Carcinoembryonic Antigen (CEA) development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Carcinoembryonic Antigen (CEA) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Carcinoembryonic Antigen (CEA) Market Size Growth Rate by Type (2014-2025)
1.4.2 CD66a
1.4.3 CD66b
1.4.4 CD66c
1.4.5 CD66d
1.4.6 CD66e
1.4.7 CD66f
1.5 Market by Application
1.5.1 Global Carcinoembryonic Antigen (CEA) Market Share by Application (2014-2025)
1.5.2 Colorectal Cancer
1.5.3 Pancreatic Cancer
1.5.4 Ovarian Cancer
1.5.5 Breast Cancer
1.5.6 Thyroid Cancer
1.5.7 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Carcinoembryonic Antigen (CEA) Market Size
2.2 Carcinoembryonic Antigen (CEA) Growth Trends by Regions
2.2.1 Carcinoembryonic Antigen (CEA) Market Size by Regions (2014-2025)
2.2.2 Carcinoembryonic Antigen (CEA) Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Carcinoembryonic Antigen (CEA) Market Size by Manufacturers
3.1.1 Global Carcinoembryonic Antigen (CEA) Revenue by Manufacturers (2014-2019)
3.1.2 Global Carcinoembryonic Antigen (CEA) Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Carcinoembryonic Antigen (CEA) Market Concentration Ratio (CR5 and HHI)
3.2 Carcinoembryonic Antigen (CEA) Key Players Head office and Area Served
3.3 Key Players Carcinoembryonic Antigen (CEA) Product/Solution/Service
3.4 Date of Enter into Carcinoembryonic Antigen (CEA) Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Carcinoembryonic Antigen (CEA) Market Size by Type (2014-2019)
4.2 Global Carcinoembryonic Antigen (CEA) Market Size by Application (2014-2019)

5 United States
5.1 United States Carcinoembryonic Antigen (CEA) Market Size (2014-2019)
5.2 Carcinoembryonic Antigen (CEA) Key Players in United States
5.3 United States Carcinoembryonic Antigen (CEA) Market Size by Type
5.4 United States Carcinoembryonic Antigen (CEA) Market Size by Application

6 Europe
6.1 Europe Carcinoembryonic Antigen (CEA) Market Size (2014-2019)
6.2 Carcinoembryonic Antigen (CEA) Key Players in Europe
6.3 Europe Carcinoembryonic Antigen (CEA) Market Size by Type
6.4 Europe Carcinoembryonic Antigen (CEA) Market Size by Application

7 China
7.1 China Carcinoembryonic Antigen (CEA) Market Size (2014-2019)
7.2 Carcinoembryonic Antigen (CEA) Key Players in China
7.3 China Carcinoembryonic Antigen (CEA) Market Size by Type
7.4 China Carcinoembryonic Antigen (CEA) Market Size by Application

8 Japan
8.1 Japan Carcinoembryonic Antigen (CEA) Market Size (2014-2019)
8.2 Carcinoembryonic Antigen (CEA) Key Players in Japan
8.3 Japan Carcinoembryonic Antigen (CEA) Market Size by Type
8.4 Japan Carcinoembryonic Antigen (CEA) Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Carcinoembryonic Antigen (CEA) Market Size (2014-2019)
9.2 Carcinoembryonic Antigen (CEA) Key Players in Southeast Asia
9.3 Southeast Asia Carcinoembryonic Antigen (CEA) Market Size by Type
9.4 Southeast Asia Carcinoembryonic Antigen (CEA) Market Size by Application

10 India
10.1 India Carcinoembryonic Antigen (CEA) Market Size (2014-2019)
10.2 Carcinoembryonic Antigen (CEA) Key Players in India
10.3 India Carcinoembryonic Antigen (CEA) Market Size by Type
10.4 India Carcinoembryonic Antigen (CEA) Market Size by Application

11 Central & South America
11.1 Central & South America Carcinoembryonic Antigen (CEA) Market Size (2014-2019)
11.2 Carcinoembryonic Antigen (CEA) Key Players in Central & South America
11.3 Central & South America Carcinoembryonic Antigen (CEA) Market Size by Type
11.4 Central & South America Carcinoembryonic Antigen (CEA) Market Size by Application

12 International Players Profiles
12.1 Roche Diagnostics
12.1.1 Roche Diagnostics Company Details
12.1.2 Company Description and Business Overview
12.1.3 Carcinoembryonic Antigen (CEA) Introduction
12.1.4 Roche Diagnostics Revenue in Carcinoembryonic Antigen (CEA) Business (2014-2019)
12.1.5 Roche Diagnostics Recent Development
12.2 Abbott Diagnostics
12.2.1 Abbott Diagnostics Company Details
12.2.2 Company Description and Business Overview
12.2.3 Carcinoembryonic Antigen (CEA) Introduction
12.2.4 Abbott Diagnostics Revenue in Carcinoembryonic Antigen (CEA) Business (2014-2019)
12.2.5 Abbott Diagnostics Recent Development
12.3 Quest Diagnostics
12.3.1 Quest Diagnostics Company Details
12.3.2 Company Description and Business Overview
12.3.3 Carcinoembryonic Antigen (CEA) Introduction
12.3.4 Quest Diagnostics Revenue in Carcinoembryonic Antigen (CEA) Business (2014-2019)
12.3.5 Quest Diagnostics Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details